Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 0 | 0 | 900 | 450 | 3,190 |
| Cost of Goods | 0 | N/A | 110 | 50 | 2,790 |
| Gross Profit | 0 | 5,940 | 790 | 400 | 400 |
| Operating Expenses | 2,560 | 11,490 | 26,640 | 16,490 | 13,780 |
| Operating Income | -2,560 | -11,490 | -25,740 | -16,040 | -12,590 |
| Other Income | 0 | 0 | 600 | 1,140 | -1,340 |
| Pre-tax Income | -2,560 | -11,490 | -25,140 | -14,900 | -13,930 |
| Income Tax | 20 | N/A | -200 | 220 | 70 |
| Net Income Continuous | 2,587 | -9,246 | -24,939 | -15,132 | -14,015 |
| Net Income | $-2,580 | $-9,246 | $-24,930 | $-15,130 | $-14,010 |
| EPS Basic Total Ops | 2.00 | -1.50 | -5.50 | -4.00 | -4.00 |
| EPS Basic Continuous Ops | 2.21 | -1.58 | -5.46 | -3.75 | -4.12 |
| EPS Diluted Total Ops | 2.00 | -1.50 | -5.50 | -4.00 | -4.00 |
| EPS Diluted Continuous Ops | 2.20 | -1.58 | -5.46 | -3.75 | -4.12 |
| EBITDA(a) | $-2,550 | $-11,460 | $-25,640 | $-15,800 | $-12,350 |